Related references
Note: Only part of the references are listed.A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
Thomas Yau et al.
INVESTIGATIONAL NEW DRUGS (2013)
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A. Ott et al.
INVESTIGATIONAL NEW DRUGS (2013)
Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase
Peter W. Szlosarek et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
Melissa M. Phillips et al.
CANCER RESEARCH AND TREATMENT (2013)
From cancer metabolism to new biomarkers and drug targets
F. Chiaradonna et al.
BIOTECHNOLOGY ADVANCES (2012)
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
M. P. Kelly et al.
BRITISH JOURNAL OF CANCER (2012)
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
L. G. Feun et al.
BRITISH JOURNAL OF CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I
Trisha R. Sippel et al.
CLINICAL CANCER RESEARCH (2011)
N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-L-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis
Van C. Willis et al.
JOURNAL OF IMMUNOLOGY (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
T-S Yang et al.
BRITISH JOURNAL OF CANCER (2010)
Directed Evolution of an Antitumor Drug (Arginine Deiminase PpADI) for Increased Activity at Physiological pH
Leilei Zhu et al.
CHEMBIOCHEM (2010)
Potential for Amino Acids Supplementation During Inflammatory Bowel Diseases
Moiese Coeffier et al.
INFLAMMATORY BOWEL DISEASES (2010)
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Evan S. Glazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
Amino acids: metabolism, functions, and nutrition
Guoyao Wu
AMINO ACIDS (2009)
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Randie H. Kim et al.
CANCER RESEARCH (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Inhibition of gastric cancer cell growth by arginine: Molecular mechanisms of action
Shayanthan Nanthakumaran et al.
CLINICAL NUTRITION (2009)
Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective
Ayala King et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1 alpha/Sp4
Wen-Bin Tsai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis
Gil Y. Melmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction
Pascal Crenn et al.
CLINICAL NUTRITION (2008)
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
Tawnya L. Bowles et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination
Brian A. Kidd et al.
ARTHRITIS RESEARCH & THERAPY (2008)
L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma
Qingyong Ma et al.
CLINICAL CANCER RESEARCH (2007)
Glutamine and interleukin-1β interact at the level of Sp1 and nuclear factor-κB to regulate argininosuccinate synthetase gene expression
Carole Brasse-Lagnel et al.
FEBS JOURNAL (2007)
A multitracer stable isotope quantification of the effects of arginine intake on whole body arginine metabolism in neonatal piglets
Kristine L. Urschel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Cheol-Yong Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
Peter W. Szlosarek et al.
CLINICAL CANCER RESEARCH (2006)
Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells
Carolyn Cao et al.
CANCER RESEARCH (2006)
L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients:: The French controlled, randomized, double-blind, multicenter study
P Déchelotte et al.
CRITICAL CARE MEDICINE (2006)
Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies
PA Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma
PNM Cheng et al.
CANCER LETTERS (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers - A method for identifying cancers sensitive to arginine deprivation
BJ Dillon et al.
CANCER (2004)
Effects of L-arginine-enriched total enteral nutrition on body weight gain, tumor growth, and in vivo concentrations of blood and tissue metabolites in rats inoculated with walker tumor in the kidney
LFG Silva et al.
NUTRITION (2004)
Acute Escherichia coli endotoxaemia decreases the plasma L-arginine/asymmetrical dimethylarginine ratio in humans
F Mittermayer et al.
CLINICAL SCIENCE (2004)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies
F Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells
C Brasse-Lagnel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells
LJ Shen et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
IS Park et al.
BRITISH JOURNAL OF CANCER (2003)
Arginine, ornithine, and proline interconversion is dependent on small intestinal metabolism in neonatal pigs
RFP Bertolo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox
J Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Arginine deprivation and tumour cell death: Arginase and its inhibition
DN Wheatley et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells
T Osanai et al.
HYPERTENSION (2003)
Cytokine-stimulated nitric oxide production and inducible NO-synthase mRNA level in human intestinal cells: lack of modulation by glutamine
R Marion et al.
CLINICAL NUTRITION (2003)
Recombinant arginine deiminase as a potential anti-angiogenic agent
K Beloussow et al.
CANCER LETTERS (2002)
Plasma amino acid levels with a note on membrane transport: Characteristics, regulation, and metabolic significance
LA Cynober
NUTRITION (2002)
Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties
FW Holtsberg et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans
P Crenn et al.
GASTROENTEROLOGY (2000)
Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension - Modulation of nitric oxide synthesis by salt intake
N Fujiwara et al.
CIRCULATION (2000)
Share Paper
